CohBar (CWBR) – Management Comments
-
CohBar (CWBR) Appoints Joseph J. Sarret, M.D., J.D. as Chief Executive Officer and Director
-
CohBar (CWBR) Reports Complete Enrollment in Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CWBR Stock Lookup